NanoMedica scientists are developing technology for single-molecule selection of drug candidates fro

"Digitizing drug discovery" refers to supersensitive, quantitative methods for decoding DNA-encoded chemical libraries.


NanoMedica scientists are developing new ways to rapidly select novel drug candidates from vast molecular libraries containing billions of DNA-encoded members with single-molecule resolution. We do so by leveraging the power of Next-Generation Sequencing to quantify the affinity of every target-binding molecule in the library.

Contact Us

Send Message